Escartín Alfredo, González Marta, Cuello Elena, Pinillos Ana, Muriel Pablo, Merichal Mireia, Palacios Victor, Escoll Jordi, Gas Cristina, Olsina Jorge-Juan
General Surgery Department, IRBLleida-University Hospital Arnau de Vilanova, Avenue Alcalde Rovira Roure 80, Lleida, Spain.
Surg Res Pract. 2019 Feb 3;2019:9709242. doi: 10.1155/2019/9709242. eCollection 2019.
The aim of this study was to evaluate the characteristics, management, and outcomes of acute cholecystitis in patients ≥80 years.
This was a retrospective analysis of data from a prospective single-center patient registry.
The study population was composed of 348 patients, which were divided into two groups: those younger (Group A) and those older (Group B) than the median age (85.4 years). Although demographic and clinical characteristics of the two groups were similar, the disease management was clearly different, with older patients undergoing cholecystectomy less frequently (=80 46.0% in Group A vs =39 22.4% in Group B; < 0.001). The outcomes in both groups of age were similar, with 30-day mortality of 3.7%, morbidity of 17.2%, and readmissions of 4.2% and two-year AC recurrence in nonoperated patients of 22.5%. No differences were seen between operated and no operated patients. Severe (Grade III) AC was the only independent factor significantly associated with mortality (OR 86.05 (95% CI: 11-679); < 0.001).
In elderly patients with AC, the choice of therapeutic options was not limited by the age per se, but rather by the disease severity (grade III AC) and/or poor physical status (ASA III-IV). In case of grade I-II AC, laparoscopic cholecystectomy can be safely performed and yield good results even in very old patients. Patients with grade III AC present high risk of morbidity and mortality, and the treatment should be individualized. ASA IV patients should avoid cholecystectomy, being antibiotic treatment and cholecystectomy the best option.
本研究旨在评估80岁及以上患者急性胆囊炎的特征、治疗及预后。
这是一项对前瞻性单中心患者登记数据的回顾性分析。
研究人群包括348例患者,分为两组:年龄低于(A组)和高于(B组)中位年龄(85.4岁)的患者。尽管两组的人口统计学和临床特征相似,但疾病治疗明显不同,老年患者接受胆囊切除术的频率较低(A组80例,占46.0%;B组39例,占22.4%;P<0.001)。两组年龄患者的预后相似,30天死亡率为3.7%,发病率为17.2%,再入院率为4.2%,非手术患者两年急性胆囊炎复发率为22.5%。手术患者和未手术患者之间未见差异。严重(III级)急性胆囊炎是与死亡率显著相关的唯一独立因素(OR 86.05(95%CI:11-679);P<0.001)。
在老年急性胆囊炎患者中,治疗方案的选择并非受年龄本身限制,而是受疾病严重程度(III级急性胆囊炎)和/或身体状况差(美国麻醉医师协会III-IV级)限制。对于I-II级急性胆囊炎患者,即使是高龄患者,腹腔镜胆囊切除术也可安全进行并取得良好效果。III级急性胆囊炎患者存在较高的发病和死亡风险,治疗应个体化。美国麻醉医师协会IV级患者应避免胆囊切除术,抗生素治疗和胆囊造瘘术是最佳选择。